$Bob's and Jbem's Bitchin' Bios

[buckiii2]

ZIOP from JPM a little bit of go.
Q&A "Very encouraged through today IL-12 Glioma - patients since June - PFS weeks - months to death - but these patients are doing well....working with FDA....


Second cohort....we can share data - major inflection point at ASCO....very encourgaged....checkpoint inhibitors not working well....so this is key - MD Anderson single center trial also coming

Dose escalation - quite confident we will get permission from Data Monitoring - we are now accelerating recruitment...- confident enough data to accelerate recruitment

Level of interest in this Glioma trial VERY HIGH - we have had to turn down patients...we are VERY optimistic.